Sath Shukla

Affiliations

  • Ceo & President at Spero Therapeutics Inc. (SPRO), 2025-02-06
  • Evp, Chief Financial Officer at Ziopharm Oncology Inc (ZIOP), 2020-01-31
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SPRO $0.78 106,408 1,736,883 2025-02-05 Filing
SPRO $0.78 42,786 1,843,291 2025-02-05 Filing
SPRO $0.78 6,139 1,886,077 2025-02-05 Filing
SPRO $1.35 2,757 1,140,809 2024-08-27 Filing
SPRO $1.31 17,641 1,143,566 2024-08-05 Filing